title: The dietary flavonoids naringenin and quercetin acutely impair glucose metabolism in rodents possibly via inhibition of hypothalamic insulin signalling.
abstract: Secondary metabolites of herbs and spices are widely used as an alternative strategy in the therapy of various diseases. The polyphenols naringenin, quercetin and curcumin have been characterised as anti-diabetic agents. Conversely, in vitro, naringenin and quercetin are described to inhibit phosphoinositide-3-kinase (PI3K), an enzyme that is essential for the neuronal control of whole body glucose homoeostasis. Using both in vitro and in vivo experiments, we tested whether the inhibitory effect on PI3K occurs in neurons and if it might affect whole body glucose homoeostasis. Quercetin was found to inhibit basal and insulin-induced phosphorylation of Akt (Ser473), a downstream target of PI3K, in HT-22 cells, whereas naringenin and curcumin had no effect. In Djungarian hamsters (Phodopus sungorus) naringenin and quercetin (10 mg/kg administered orally) diminished insulin-induced phosphorylation of Akt (Ser473) in the arcuate nucleus, indicating a reduction in hypothalamic PI3K activity. In agreement with this finding, glucose tolerance in naringenin-treated hamsters (oral) and mice (oral and intracerebroventricular) was reduced compared with controls. Dietary quercetin also impaired glucose tolerance, whereas curcumin was ineffective. Circulating levels of insulin and insulin-like growth factor-binding protein were not affected by the polyphenols. Oral quercetin reduced the respiratory quotient, suggesting that glucose utilisation was impaired after treatment. These data demonstrate that low doses of naringenin and quercetin acutely and potently impair glucose homoeostasis. This effect may be mediated by inhibition of hypothalamic PI3K signalling. Whether chronic impairments in glucose homoeostasis occur after long-term application remains to be identified.
authors: Department of Animal Physiology, Faculty of Biology, Philipps University Marburg, Marburg, Germany.
authors: Christiane E
authors: CE
authors: Koch
authors: Goutham K
authors: GK
authors: Ganjam
authors: Juliane
authors: J
authors: Steger
authors: Karen
authors: K
authors: Legler
authors: Sigrid
authors: S
authors: Stöhr
authors: Daniela
authors: D
authors: Schumacher
authors: Nigel
authors: N
authors: Hoggard
authors: Gerhard
authors: G
authors: Heldmaier
authors: Alexander
authors: A
authors: Tups
mesh_terms: D000818:Animals; D001111:Arcuate Nucleus of Hypothalamus / Q000378:metabolism; D002460:Cell Line; D006224:Cricetinae; D004032:Diet; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D044950:Flavanones / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism*; D018149:Glucose Intolerance / Q000139:chemically induced; D006706:Homeostasis / Q000187:drug effects; D007004:Hypoglycemic Agents; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D018971:Insulin-Like Growth Factor Binding Protein 2 / Q000097:blood; D051379:Mice; D017111:Phodopus; D000081082:Phosphoinositide-3 Kinase Inhibitors; D010766:Phosphorylation / Q000187:drug effects; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D011794:Quercetin / Q000494:pharmacology*; D015398:Signal Transduction / Q000187:drug effects*
chemical_list: D004791:Enzyme Inhibitors; D044950:Flavanones; D007004:Hypoglycemic Agents; D007328:Insulin; D018971:Insulin-Like Growth Factor Binding Protein 2; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011794:Quercetin; D051057:Proto-Oncogene Proteins c-akt; C005273:naringenin; D005947:Glucose